Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-21-016839

Chief Executive Officer gave up 798 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kulkarni Samarth Chief Executive Officer 2021-03-01 Shares withheld for taxes −798 $130.25 $103,940 182,191 D
Loading xslF345X03/doc4.xml…